Hepatitis C virus: prevention, screening, and interpretation of assays.
作者： Mazen Albeldawi , Ernesto Ruiz-Rodriguez , William D. Carey
关键词:
摘要: Patients at risk of hepatitis C virus (HCV) infection should be screened for it so that they can treated and potentially cured, or least avoid transmitting the disease to others. The authors describe why how screen HCV interpret test results.
cabdirect.org
sci-hub.st 参考文章(57)
Linda Hill, Bonnie Henry, Suzanne Schweikert, Jennifer K. Bretsch, Screening for chronic hepatitis C: American College of Preventive Medicine practice policy statement American Journal of Preventive Medicine. ,vol. 28, pp. 327- 330 ,(2005) , 10.1016/J.AMEPRE.2004.12.009
James Bell, Robert G Batey, Geoffrey C Farrell, Evelyn B Crewe, Anthony L Cunningham, Karen Byth, Hepatitis C virus in intravenous drug users. The Medical Journal of Australia. ,vol. 153, pp. 274- 276 ,(1990) , 10.5694/J.1326-5377.1990.TB136900.X
S A Villano, D Vlahov, K E Nelson, C M Lyles, S Cohn, D L Thomas, Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland. Journal of Clinical Microbiology. ,vol. 35, pp. 3274- 3277 ,(1997) , 10.1128/JCM.35.12.3274-3277.1997
Bruce P. Lanphear, Calvin C. Linnemann, Constance G. Cannon, Martha M. DeRonde, Luann Pendy, Lisa M. Kerley, Hepatitis C virus infection in healthcare workers: risk of exposure and infection. Infection Control and Hospital Epidemiology. ,vol. 15, pp. 745- 750 ,(1994) , 10.2307/30148418
Thomas McGinn, Nicola O’Connor-Moore, David Alfandre, Donald Gardenier, Juan Wisnivesky, Validation of a Hepatitis C Screening Tool in Primary Care Archives of Internal Medicine. ,vol. 168, pp. 2009- 2013 ,(2008) , 10.1001/ARCHINTE.168.18.2009
Jean-Francois Rossignol, Asem Elfert, Emmet B. Keeffe, Treatment of chronic hepatitis C using a 4-week lead-in with nitazoxanide before peginterferon plus nitazoxanide. Journal of Clinical Gastroenterology. ,vol. 44, pp. 504- 509 ,(2009) , 10.1097/MCG.0B013E3181BF9B15
C. LEE, G. DUSHEIKO, The natural history and antiviral treatment of hepatitis C in haemophilia. Haemophilia. ,vol. 8, pp. 322- 329 ,(2002) , 10.1046/J.1365-2516.2002.00620.X
Norio Hayashi, Tetsuo Takehara, Antiviral therapy for chronic hepatitis C: past, present, and future. Journal of Gastroenterology. ,vol. 41, pp. 17- 27 ,(2006) , 10.1007/S00535-005-1740-7
Fredric D. Gordon, Cost-effectiveness of screening patients for hepatitis C The American Journal of Medicine. ,vol. 107, pp. 36- 40 ,(1999) , 10.1016/S0002-9343(99)00379-4
Garth E. Austin, William De L’Aune, Bette Jensen, Jean Leete, Julu Bhatnagar, Joshua E. Braun, Michele Racine, Prevalence of Hepatitis C Virus Seropositivity among Hospitalized US Veterans The American Journal of the Medical Sciences. ,vol. 319, pp. 353- 359 ,(2000) , 10.1016/S0002-9629(15)40773-6